Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01475812
Other study ID # 0353/03
Secondary ID
Status Completed
Phase N/A
First received November 17, 2011
Last updated November 18, 2011
Start date March 2007

Study information

Verified date November 2011
Source Federal University of São Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Observational

Clinical Trial Summary

Introduction: Chronic obstructive pulmonary disease is a condition characterized by airflow limitation usually progressive and associated with inflammatory response of lung noxious particles. During a physical activity chronic obstructive pulmonary disease patients may develop dynamic pulmonary hyperinflation, increased dyspnea perception and decreased activity performance. The investigators hypothesize that some specific activities of daily living induce dynamic pulmonary hyperinflation in COPD patients. Objective: To measure dynamic lung hyperinflation and its influence in dyspnea perception in moderate and severe chronic obstructive pulmonary disease patients after activities of daily living. Methods: The investigators measured inspiratory capacity, dyspnea sensation, peripheral oxygen saturation, heart rate and respiratory rate in 19 chronic obstructive pulmonary disease (COPD) patients. These measurements were taken at rest and after daily living activities (such as going up and down a set of stairs, going up and down a ramp and sweeping and mopping a room).


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria:

- COPD patients diagnosed with moderate to very severe airway obstruction according to GOLD classification (9)

- clinical stability with no clinical exacerbation during the previous 30 days prior to the beginning of the study and to sign an informed consent form

Exclusion Criteria:

- Inability to perform the slow vital capacity maneuver

- excessive perceived dyspnea during the test

- arterial oxyhemoglobin saturation (SpO2) lower than 80% during activities and/or need of oxygen supplementation

Study Design

Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Other:
Hyperinflation and ADL
Assessment of dynamic pulmonary hyperinflation during activities of daily living in COPD patients.

Locations

Country Name City State
Brazil Federal University of São Paulo São Paulo São Paulo/SP

Sponsors (1)

Lead Sponsor Collaborator
Federal University of São Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Inspiratory capacity variability within the accomplishment of activities of daily living in COPD patients. 3 months No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05980611 - Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients
Recruiting NCT00949195 - Pulmonary Arterial Pressure Response During Exercise N/A
Completed NCT06128902 - The Effect of Home-Based Monitoring, Exercise Training N/A
Completed NCT02157935 - Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease Phase 3
Completed NCT01183052 - Mitochondrial Dysfunction and Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD) Patients N/A
Withdrawn NCT00180622 - Markers for Chronic Obstructive Pulmonary Disease (COPD)
Completed NCT04869033 - Effects of Farinelli's Breathing Exercise in COPD Patients N/A
Completed NCT02099279 - Prognostic Value Cardiac Dysfunction Assessed by Bedside Echocardiography in Critically Ill COPD Patients Requiring Mechanical Ventilation N/A
Withdrawn NCT00361426 - EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients N/A
Recruiting NCT03774238 - Determinants of the Vascular Response to Training in Chronic Obstructive Pulmonary Disease (COPD) Patients N/A
Enrolling by invitation NCT03851991 - The Efficacy and Safety of Arbidol in Reducing the Frequency of AECOPD. Phase 4